Skip to main content
SpringerLink
Log in

The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients

  • Original Articles
  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

The immunohistochemical expression of DF3 antigen and serum concentrations of CA15-3, a breast carcinoma-associated antigen recognized by the monoclonal antibodies (MAbs) 115D8 and DF3, was investigated in breast cancer patients. The levels of serum CA15-3 in 23 primary breast cancer patients did not correlate to the percentage cytoplasmic reactivity of MAb DF3 with the carcinoma cells in tissue specimens from each respective patients. In 17 patients who subsequently developed metastatic breast cancer, however, the serum CA15-3 concentrations generally correlated well to the cytoplasmic reactivity of MAb DF3 with the carcinoma cells in specimens obtained at initial biopsy or mastectomy. Elevated levels of serum CA15-3 were seen in metastatic breast cancer patients when the carcinoma cells in their primary specimens expressed enhanced levels of cytoplasmic DF3 antigen. The results of this study suggest that the immunohistochemical demonstration of DF3 antigen in tissue specimens, together with the periodical measurement of circulating CA15-3 antigen, may be important for monitoring the clinical course of breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kufe DW, Inghirami G, Abe M, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignantversus benign breast tumors. Hybridoma 1984; 3: 223–232.

    Article  PubMed  CAS  Google Scholar 

  2. Ohuchi N, Page DL, Merino M, Viglione MJ, Kufe DF, Schlom J. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast. J Natl Cancer Inst 1987; 79: 109–117.

    PubMed  CAS  Google Scholar 

  3. Page DL, Dupont W, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. Cancer 1985; 55: 2698–2708.

    Article  PubMed  CAS  Google Scholar 

  4. Ohuchi N, Abe R, Kasai M. Possible cancerous change of intraductal papillomas of the breast: a 3-D reconstruction study of 25 cases. Cancer 1984; 54: 605–611.

    Article  PubMed  CAS  Google Scholar 

  5. Lundy J, Thor A, Maenza R, Schloma J, Forouhar F, Testa M, Kufe D. Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients. Breast Cancer Res Treat 1985; 5: 269–276.

    Article  PubMed  CAS  Google Scholar 

  6. Colomer R, Sole LA, Navarro, M. CA15-3; early results of a new breast cancer marker Anticancer Res 1986; 4: 683–684.

    Google Scholar 

  7. Tobias R, Rothwell C, Wagner J, Green A, Liu YS. Development and evaluation of a radioimmunoassay for the detection of a monoclonal antibody defined breast tumor associated antigen 115D8/DF3. J Am Assoc Clin Chem 1985; 31: 986–992.

    Google Scholar 

  8. Hayes DF, Zurawski VR Jr, Kufe DW. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 1986; 4: 1542–1550.

    PubMed  CAS  Google Scholar 

  9. van Dalen A, Bonfrer JMG, Dupree H, Heering KH, van der Linde, Nooijen WJ. CA15-3 as a marker in the follow-up of patients with breast cancer. In: Wust G, ed. Tumormarker. Darmstadt: Steinkopff Verlag 1987; 182–185.

    Google Scholar 

  10. Tondini C, Hayes DF, Gelman R, Henderson IC, Kufe DW. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Cancer Res 1988; 48: 4107–4117.

    PubMed  CAS  Google Scholar 

  11. Hilkens J, Buijs F, Higers J, Hageman Ph, Calafat J, Sonnenberg A, van der Valk M. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984; 34: 197–206.

    PubMed  CAS  Google Scholar 

  12. Hilkens J, Kroezen V, Bonfrer JMG, De Jong-Bakker M, Bruning PF. MAM-6 antigen, a new serum marker for breast cancer monitoring. Cancer Res 1986; 46: 2582–2587.

    PubMed  CAS  Google Scholar 

  13. Sekine H, Ohno T, Kufe DW. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas. J Immunol 1985; 135: 3610–3615.

    PubMed  CAS  Google Scholar 

  14. Abe M, Kufe DW. Sodium butylate induction of milk-related antigens in human MCF-7 breast carcinoma cells. Cancer Res 1984; 44: 4574–4577.

    PubMed  CAS  Google Scholar 

  15. Hayes DF, Sekine H, Ohno T, Abe M, Keefe K, Kufe DW. Use of murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest 1985; 75: 1671–1678.

    Article  PubMed  CAS  Google Scholar 

  16. Remington RD, Schork MA. Statistics with applications to the biological and health sciences. Engliwood Cliffs, New Jersey: Prentice-Hall 1970; 313–315.

    Google Scholar 

  17. Tormey DC, Waalkes TP, Snyder J, Simon RM. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. Cancer 1977; 39: 2397–2404.

    Article  PubMed  CAS  Google Scholar 

  18. Thompson RJ, Rubery E, Jones HM. Radioimmunoassay of serum creatine kinase-BB as a tumor marker in breast cancer. Lancet 1980; 2: 673–675.

    Article  PubMed  CAS  Google Scholar 

  19. Dao T, Ip C, Patel J. Serum sialyltransferase and 5′-nucleotidase as reliable biomarkers in breast cancer. J Natl Cancer Inst 1980; 65: 529–534.

    PubMed  CAS  Google Scholar 

  20. Schapira D, Schapira M. Use of ceruloplasmine levels to monitor response to therapy and predict recurrence of breast cancer. Breast Cancer Res Treat 1983; 3: 221–224.

    Article  PubMed  CAS  Google Scholar 

  21. Loprinzi CL, Tormey DC, Rasmussen P, Falkson G, Chang AY. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. J Clin Oncol 1986; 4: 46–56.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Clinical Laboratory, Sendai City Hospital, Sendai, Japan

    Shin-ichi Sato & Kenji Takahashi

  2. Department of Surgery, Sendai City Hospital, Sendai, Japan

    Yukio Taira & Naoya Matoba

  3. The Second Department of Surgery, Tohoku University School of Medicine, 1-1 Seiryomachi, Aoba-ku, 981, Sendai, Japan

    Noriaki Ohuchi MD, Minoru Akimoto & Shozo Mori

Authors
  1. Noriaki Ohuchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shin-ichi Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Minoru Akimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yukio Taira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naoya Matoba
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenji Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shozo Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohuchi, N., Sato, Si., Akimoto, M. et al. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients. The Japanese Journal of Surgery 21, 129–137 (1991). https://doi.org/10.1007/BF02470899

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02470899

Key Words

Search

Navigation